Publications by authors named "Niklas Muenchmeier"

Claim this Profile
A
A multicenter retrospective evaluation of Chronic Myeloid Leukemia (CML) therapy in Austria assessing the impact of early treatment response on patient outcomes in a real-life setting : R-EFECT study.
Andreas L Petzer, Wolfgang R Sperr, Veronika Buxhofer-Ausch, Thamer Sliwa, Stefan Schmidt, Niklas Muenchmeier

Wien Klin Wochenschr· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear transfer nTreg model reveals fate-determining TCR-β and novel peripheral nTreg precursors.
Manching Ku, Shih-En Chang, Julio Hernandez, Justin R Abadejos, Mohsen Sabouri-Ghomi, Niklas J Muenchmeier

Proc Natl Acad Sci U S A· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel CXCL10-based GPI-anchored fusion protein as adjuvant in NK-based tumor therapy.
Niklas Muenchmeier, Sophia Boecker, Lorenz Bankel, Laura Hinz, Nicole Rieth

PLoS One· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Membrane-anchored chemokine fusion proteins: A novel class of adjuvants for immunotherapy.
Peter J Nelson, Niklas Muenchmeier

Oncoimmunology· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SDF-1 fused to a fractalkine stalk and a GPI anchor enables functional neovascularization.
Georg Stachel, Teresa Trenkwalder, Franziska Götz, Chiraz El Aouni, Niklas Muenchmeier

Stem Cells· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human renal cell carcinoma induces a dendritic cell subset that uses T-cell crosstalk for tumor-permissive milieu alterations.
Ainhoa-M Figel, Dorothee Brech, Petra U Prinz, Ulrike K Lettenmeyer, Judith Eckl, Niklas Muenchmeier

Am J Pathol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel CXCL8 protein-based antagonist in acute experimental renal allograft damage.
Jens Bedke, Peter J Nelson, Eva Kiss, Niklas Muenchmeier, Angelika Rek

Mol Immunol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peritumoral administration of GPI-anchored TIMP-1 inhibits colon carcinoma growth in Rag-2 gamma chain-deficient mice.
Matthias C Raggi, Roghieh Djafarzadeh, Niklas Muenchmeier, Monika Hofstetter, Birgit Jahn

Biol Chem· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis